Discovery of Thiophene Derivatives as Potent, Orally Bioavailable, and Blood–Brain Barrier-Permeable Ebola Virus Entry Inhibitors
Journal of Medicinal Chemistry · 2024
DOI: 10.1021/acs.jmedchem.4c01267 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2024. Verfasst von Marcos Morales-Tenorio und 11 weiteren Autor:innen. Beteiligte Einrichtung: Centro de Investigaciones Biológicas Margarita Salas (CIB-CSIC), Madrid 28040, Spain. Hauptthemen laut MEDLINE: Thiophenes, Ebolavirus, Blood-Brain Barrier, Antiviral Agents. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Commission, Agencia Estatal de Investigaci?n, Ministerio de Ciencia e Innovaci?n.
Abstract (Originalsprache)
The endemic nature of the Ebola virus disease in Africa underscores the need for prophylactic and therapeutic drugs that are affordable and easy to administer. Through a phenotypic screening employing viral pseudotypes and our in-house chemical library, we identified a promising hit featuring a thiophene scaffold, exhibiting antiviral activity in the micromolar range. Following up on this thiophene hit, a new series of compounds that retain the five-membered heterocyclic scaffold while modifying several substituents was synthesized. Initial screening using a pseudotype viral system and validation assays employing authentic Ebola virus demonstrated the potential of this new chemical class as viral entry inhibitors. Subsequent investigations elucidated the mechanism of action through site-directed mutagenesis. Furthermore, we conducted studies to assess the pharmacokinetic profile of selected compounds to confirm its pharmacological and therapeutic potential.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Centro de Investigaciones Biológicas Margarita Salas (CIB-CSIC), Madrid 28040, Spain.
- Instituto de Investigación Hospital 12 de Octubre,, Madrid 28041, Spain.
- Bernhard Nocht Institute for Tropical Medicine, Hamburg 20359, Germany.
- Dpt. Biotechnology, Instituto Nacional de Investigación y Tecnología Agraria y Alimentaria (INIA-CSIC), Madrid 28040, Spain.
- CIBERNED, Instituto Salud Carlos III, Madrid 28029, Spain.
- CIBERINFEC, Instituto Salud Carlos III, Madrid 28029, Spain.
ORCID-Profile: Ana Martínez, Carmen Gil
Förderung
- European Commission
- Agencia Estatal de Investigaci?n
- Ministerio de Ciencia e Innovaci?n
- 'la Caixa' Foundation
- Horizon 2020 Framework Programme
- Instituto de Salud Carlos III
Zitieren
APA
Morales-Tenorio, M., Lasala, F., Garcia-Rubia, A., Aledavood, E., Heung, M., Olal, C., Escudero-Pérez, B., Alonso, C., Martínez, A., Muñoz-Fontela, C., Delgado, R., & Gil, C. (2024). Discovery of Thiophene Derivatives as Potent, Orally Bioavailable, and Blood–Brain Barrier-Permeable Ebola Virus Entry Inhibitors. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.4c01267
Vancouver
Morales-Tenorio M, Lasala F, Garcia-Rubia A, Aledavood E, Heung M, Olal C, et al. Discovery of Thiophene Derivatives as Potent, Orally Bioavailable, and Blood–Brain Barrier-Permeable Ebola Virus Entry Inhibitors. Journal of Medicinal Chemistry. 2024. doi:10.1021/acs.jmedchem.4c01267
BibTeX
@article{MoralesTenorio2024,
author = {Morales-Tenorio, Marcos and Lasala, Fátima and Garcia-Rubia, Alfonso and Aledavood, Elnaz and Heung, Michelle and Olal, Catherine and Escudero-Pérez, Beatriz and Alonso, Covadonga and Martínez, Ana and Muñoz-Fontela, César and Delgado, Rafael and Gil, Carmen},
title = {Discovery of Thiophene Derivatives as Potent, Orally Bioavailable, and Blood–Brain Barrier-Permeable Ebola Virus Entry Inhibitors},
journal = {Journal of Medicinal Chemistry},
year = {2024},
doi = {10.1021/acs.jmedchem.4c01267}
}
EUVIMED